EX-FILING FEES 4 tm2329697d2_ex-filingfees.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3ASR

(Form Type)

 

Celldex Therapeutics, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security
Class Title		   Fee
Calculation
or Carry
Forward
Rule		     Amount
Registered		     Proposed
Maximum
Offering
Price Per
Unit		     Maximum
Aggregate
Offering
Price		     Fee
Rate		 Amount of
Registration
Fee		 Carry
Forward
Form
Type		 Carry
Forward File
Number		 Carry
Forward
Initial
Effective
Date		 Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward		      
Fees to Be Paid   Equity   Common Stock, par value $0.001 per share     Rule 456(b) and Rule 457(r)       (1)       (1)       (1)       (2)   (2)              
Fees to Be Paid   Equity   Preferred Stock, par value $0.01 per share     Rule 456(b) and Rule 457(r)       (1)       (1)       (1)       (2)   (2)              
Fees to Be Paid   Other   Warrants     Rule 456(b) and Rule 457(r)       (1)       (1)       (1)       (2)   (2)              
Fees to Be Paid   Other   Depositary Shares             (1)       (1)       (1)       (2)   (2)              
Fees to Be Paid   Other   Units     Rule 456(b) and Rule 457(r)       (1)       (1)       (1)       (2)   (2)              
Fees Previously Paid   N/A   N/A     N/A       N/A       N/A       N/A           N/A              
Carry Forward Securities
Carry Forward Securities   N/A   N/A     N/A       N/A               N/A             N/A N/A N/A N/A      
    Total Offering Amounts       N/A           N/A              
    Total Fees Previously Paid                   N/A              
    Total Fee Offsets                   N/A              
    Net Fee Due                   N/A              

 

(1) An indeterminate aggregate initial offering price and number of securities of each identified class is being registered as may from time to time be offered, issued or sold at indeterminate prices. In addition, an indeterminate number of securities that may be issued upon exercise, settlement, conversion or exchange of any offered securities, or pursuant to anti-dilution adjustments, is being registered. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities..
(2) In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the Registrant is deferring payment of the entire registration fee. Any registration fees will be paid subsequently on a “pay-as-you-go” basis.